Sartorius is expanding its bioanalytical portfolio by acquiring a majority stake in ALS Automated Lab Solutions GmbH. A laboratory technology company based in Jena, Germany, develops, manufactures and sells solutions for automated cell analysis, selection and isolation.
With these solutions, ALS allows users to significantly reduce the time to results and the cost of cell line development and antibody detection. Other areas of application are the development of cellular and gene therapy, as well as the rare single-cell molecular diagnostics in cancer and prenatal research.
Read the official announcement of the manufacturer here.